Menu

 

All Sites Sorted » Health Beauty and Fitness » Medicine


 


Sponsored

 

Latest News

Why Aegerion Pharmaceuticals (AEGR) Stock Is Surging in After-Hours Trading Today
NEW YORK (TheStreet) -- Aegerion Pharmaceuticals  surged in after-hours trading Tuesday after the company reported second-quarter earnings that beat analysts' expectations and guided full-year Juxtapid sales above the consensus estimate. Aegerion reported a loss of 33 cents a share, narrower than the consensus estimate of a loss of 41 cents a share. Juxtapid sales totaled $36 million, which beat ... Tue, 29 Jul 2014 14:28:39 -0700

Aegerion Pharmaceuticals Announces Second-Quarter 2014 Financial Results
- Company achieves $36.0 million in net product sales of JUXTAPID(R) with 34% growth in sales over first quarter Tue, 29 Jul 2014 13:15:00 -0700

Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences
MOUNTAIN VIEW, Calif., July 29, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (ALXA) announced today that it is participating in two healthcare conferences during the third quarter, the 2014 Avondale Partners Healthcare 1-1 Conference and the Morgan Stanley Global Healthcare 2014 Conference.  Alexza's corporate presentation will be webcast live from the Morgan Stanley Conference.  The ... Tue, 29 Jul 2014 13:15:00 -0700

ACADIA Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 5, 2014
ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2014 on Tuesday, August 5, 2014, after the U.S. Tue, 29 Jul 2014 06:00:00 -0700

Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000
RESEARCH TRIANGLE PARK, N.C., July 29, 2014 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it has been awarded a Phase I grant from the National Science Foundation Small Business Innovation Research (NSF SBIR) program. Cloud Pharmaceuticals designs new drugs and drug candidates and accelerates the ... Tue, 29 Jul 2014 05:30:00 -0700

Bohai Pharmaceuticals Updates Corporate Website
YANTAI, CHINA / ACCESSWIRE / July 28, 2014 / Bohai Pharmaceuticals Group, Inc. ( OTCQB: BOPH ) , a leading manufacturer and marketer of traditional Chinese medicine (TCM), today said it has updated its ... Tue, 29 Jul 2014 05:15:00 -0700

AMAG Pharmaceuticals Announces Second Quarter and Six Month 2014 Financial Results and Updates Financial Guidance for ...
Record Physician Demand Drives 27% Increase in U.S. Net Feraheme Revenues Tue, 29 Jul 2014 04:00:00 -0700

Use Options For a Chance To Buy BioCryst Pharmaceuticals at a 65% Discount
Looking back to 61 days ago, BioCryst Pharmaceuticals, Inc. (NASD: BCRX) priced a $100,000,000 secondary stock offering at $10.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 12.4% higher than the offering price. Mon, 28 Jul 2014 08:57:35 -0700

Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call
ALISO VIEJO, Calif. -- Avanir Pharmaceuticals, Inc. will report financial results for the quarter ended June 30, 2014 after market close on Tuesday, August 5, 2014. The company will conduct a conference ... Mon, 28 Jul 2014 05:30:00 -0700

Why AMAG Pharmaceuticals (AMAG) Could Be Positioned for a Slump
AMAG Pharmaceuticals one such stock that can be considered to drop as it has witnessed a significant price decline and has seen negative earnings Mon, 28 Jul 2014 04:06:09 -0700

Website Directory Sort by: Hits | Alphabetical

Features

Top 5 Web Hosts
(Largest)


Top 5 Favorite Web Hosts

   1. HostGator
   2. LunarPages
   3. Yahoo! Web Hosting
   4. HostMonster
   5. BlueHost